LG LGAX4750 Owner's Manual - Page 121

The FDA is working with the U.S. National Toxicology Program

Page 121 highlights

causing agent and the time tumors develop - if they do - may be many, many years. The interpretation of epidemiological studies is hampered by difficulties in measuring actual RF exposure during day-to-day use of wireless phones. Many factors affect this measurement, such as the angle at which the phone is held, or which model of phone is used. 6. What is the FDA doing to find out more about the possible health effects of wireless phone RF? The FDA is working with the U.S. National Toxicology Program and with groups of investigators around the world to ensure that high priority animal studies are conducted to address important questions about the effects of exposure to Radio Frequency (RF) energy . The FDA has been a leading participant in the World Health Organization International Electromagnetic Fields (EMF) Project since its inception in 1996. An influential result of this work has been the development of a detailed agenda of research needs that has driven the establishment of new research programs around the world. The project has also helped develop a series of public information documents on EMF issues. The FDA and the Cellular Telecommunications & Internet Association (CTIA) have a formal Cooperative Research and Development Agreement (CRADA) to do research on wireless phone safety. The FDA provides the scientific oversight, obtaining input from experts in government, industry, and academic organizations. CTIA-funded research is conducted through contracts with independent investigators. The initial research will include both laboratory studies and studies of wireless phone users. The CRADA will also include a broad assessment of additional research needs in the context of the latest research developments around the world. AX4750 121

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137

121
AX4750
causing agent and the time tumors develop — if they do — may
be many, many years. The interpretation of epidemiological
studies is hampered by difficulties in measuring actual RF
exposure during day-to-day use of wireless phones. Many
factors affect this measurement, such as the angle at which the
phone is held, or which model of phone is used.
6.
What is the FDA doing to find out more about the
possible health effects of wireless phone RF?
The FDA is working with the U.S. National Toxicology Program
and with groups of investigators around the world to ensure that
high priority animal studies are conducted to address important
questions about the effects of exposure to Radio Frequency (RF)
energy .
The FDA has been a leading participant in the World Health
Organization International Electromagnetic Fields (EMF) Project
since its inception in 1996. An influential result of this work has
been the development of a detailed agenda of research needs
that has driven the establishment of new research programs
around the world. The project has also helped develop a series
of public information documents on EMF issues. The FDA and
the Cellular Telecommunications & Internet Association (CTIA)
have a formal Cooperative Research and Development
Agreement (CRADA) to do research on wireless phone safety.
The FDA provides the scientific oversight, obtaining input from
experts in government, industry, and academic organizations.
CTIA-funded research is conducted through contracts with
independent investigators. The initial research will include both
laboratory studies and studies of wireless phone users. The
CRADA will also include a broad assessment of additional
research needs in the context of the latest research
developments around the world.